Source: Annual Congress 2006 - Cystic fibrosis: aerosol treatment and non–pulmonary complications
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. V. Gorinova, I. K. Volkov, L. A. Scheplyagina (Moscow, Russian Federation). Biochemical markers of bone remodeling in children with chronic lung diseases. Eur Respir J 2006; 28: Suppl. 50, 1521

Member's Comments

No comment yet.

Related content which might interest you: Mineralization and bone tissue metabolism in children with chronic inflammatory bronchopulmonary diseases Source: Eur Respir J 2003; 22: Suppl. 45, 318s Year: 2003 Plasma inflammatory markers associated with bone resorption in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008 Role of serum and tissue vascular remodeling markers in bone loss related to end-stage COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Bone turnover markers, bone mineral density and body composition in Tunisian patients with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021 Loss of bone mineral density in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Primary care management of COPD Year: 2007 Inflammatory mediators associated with bone metabolism in patients awaiting lung transplantation Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012 Resorptive-destructive processes of bone tissue in COPD patients Source: International Congress 2019 – Asthma and COPD comorbidities Year: 2019 Biomarkers to predict decreased bone mineral density in patients with chronic respiratory failure Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Cytokines, bone markers and weight in patients with advanced pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 586s Year: 2005 Bone mineral density changes in male patients with chronic obstructive pulmonary disease: clinical and biochemical variables in correlation with glucocorticoids use Source: Annual Congress 2009 - Healthcare and treatment of COPD Year: 2009 Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Interstitial lung diseases in infants and children Source: Eur Respir J 2008; 31: 658-666 Year: 2008 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure Source: Eur Respir J 2015; 46: 1430-1439 Year: 2015 Nutritional modulation to correct metabolic alterations in chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020 Study of bone mineral density, hemogram and their correlations in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Genetic features of decrease in lung function in various forms of a chronic bronchitis Source: Eur Respir J 2005; 26: Suppl. 49, 518s Year: 2005 Monitoring of lung function and airways inflammation after bone marrow transplantation Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008 Molecular mechanisms of lung tissue remodeling in progression of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 Epidemiological profile of chronic interstitial lung diseases in Tunisian patients Source: International Congress 2017 – ILDs: clinical problems Year: 2017